Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase 1/2 1

Status

Completed 5Unknown 2Terminated 2Withdrawn 1Active not recruiting 1

Sponsor Class

INDUSTRY 6OTHER 5

Study Type

Interventional 5

Sponsor

Cancer Type

Genitourinary 5

Conditions

Breast Neoplasms 4354Neoplasms 3056Prostatic Neoplasms 1904Colorectal Neoplasms 1739Lung Neoplasms 1555Carcinoma, Non-Small-Cell Lung 1270Pancreatic Neoplasms 981Leukemia, Myeloid, Acute 952Multiple Myeloma 951Lymphoma 912Head and Neck Neoplasms 894Leukemia 852Precursor Cell Lymphoblastic Leukemia-Lymphoma 833Neoplasm Metastasis 793Colonic Neoplasms 785Carcinoma, Hepatocellular 762Ovarian Neoplasms 757Melanoma 752Stomach Neoplasms 742Rectal Neoplasms 701Brain Neoplasms 696Lymphoma, Non-Hodgkin 663Leukemia, Lymphocytic, Chronic, B-Cell 618Uterine Cervical Neoplasms 607Lymphoma, Follicular 559Glioblastoma 541Recurrence 539Hodgkin Disease 532Esophageal Neoplasms 527Myelodysplastic Syndromes 508

Interventions

epothilone B 1cabazitaxel 1Everolimus 14-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Completed × OTHER × Hormone Refractory Prostate Cancer × Clear all
NCT01741116 2021-02-18

Dovitinib(TKI258) in Patients With Castration-resistant Prostate Cancer

Korean Cancer Study Group

Phase 2 Completed
44 enrolled
Genitourinary

Hormone Refractory Prostate Cancer

NCT00928252 2017-08-14

Chemotherapy Response Monitoring With 18F-choline PET/CT in Hormone Refractory Prostate Cancer

Queen's Medical Center

Phase 1/2 Completed
25 enrolled 9 charts
Genitourinary

Hormone Refractory Prostate Cancer

NCT01518283 2017-07-02

Study of Weekly Cabazitaxel for Advanced Prostate Cancer

Spanish Oncology Genito-Urinary Group

Phase 2 Completed
74 enrolled
Genitourinary

Hormone Refractory Prostate Cancer

NCT00629525 2015-03-03

RAD001 in Patients With Metastatic, Hormone-Refractory Prostate Cancer

Duke University

Phase 2 Completed
35 enrolled 6 charts
Genitourinary

Hormone Refractory Prostate Cancer

NCT00407251 2010-11-05

Study of Patupilone in Prostate Cancer Patients Who Progress After Hormone Therapy and Docetaxel Chemotherapy

British Columbia Cancer Agency

Phase 2 Completed
73 enrolled
Genitourinary

Hormone Refractory Prostate Cancer

Data powered by HemOnc (CC BY 4.0) Colophon âš¡